GLI3 rs10263647: Muscle Fiber Growth & Training Response
The genetic variant rs10263647 is a common single nucleotide polymorphism located in an intron of the GLI3 gene on chromosome 7. Research has linked this variant to differences in skeletal muscle fiber hypertrophy and satellite cell proliferation in response to structured resistance training. Individuals carrying the C allele appear to display greater myofiber cross-sectional area growth compared to those homozygous for the T allele.
What each genotype means
| Genotype | What the research suggests | Reading |
|---|---|---|
| CC | Carriers of the CC genotype possess two copies of the C allele. In resistance training research cohorts, this genotype has been associated with significant increases in muscle fiber cross-sectional area, satellite cell proliferation, and myonuclear addition after mechanical training. | Favorable |
| CT | Carriers of the CT (or T/C) genotype possess one C allele and one T allele. Research cohorts indicate that individuals with this heterozygous genotype experience muscle fiber hypertrophy and satellite cell pool expansion comparable to CC individuals in response to resistance training. | Favorable |
| TT | Carriers of the TT genotype possess two copies of the T allele. In published exercise genomics studies, this genotype was associated with a comparatively blunted muscle fiber hypertrophy response and an absence of significant myonuclear addition following resistance exercise protocols. | Informational |
Genetic Architecture and Genomic Location
The single nucleotide polymorphism designated rs10263647 is situated on chromosome 7 at genomic position 41971865 (GRCh38 assembly). It represents a single-base transition involving thymine (T) and cytosine (C). The variant resides within an intronic region of the GLI family zinc finger 3 (GLI3) gene, meaning it lies outside the protein-coding exons. Because intronic variations do not directly change the amino acid sequence of the final protein, their functional roles typically stem from potential alterations in pre-mRNA splicing, transcription factor binding affinity, or regional chromatin organization. While non-coding variants are sometimes mere genetic markers inherited alongside true functional changes through linkage disequilibrium, intronic polymorphisms in human physiology have repeatedly been documented to modulate gene expression levels or alter relative isoform production.
Biological Function of the GLI3 Gene in Muscle
The GLI3 gene encodes a zinc finger transcription factor that serves as a key downstream effector in the Hedgehog signaling pathway. Depending on post-translational proteolytic cleavage, GLI3 can function as either a transcriptional activator or a transcriptional repressor. Beyond its critical developmental roles in embryogenesis and limb patterning, biological research in muscle biology demonstrates that GLI3 signaling plays a vital role in regulating adult muscle stem cells, often called satellite cells. Satellite cells are quiescent stem cells positioned along mature muscle fibers that activate, proliferate, and fuse to existing fibers in response to mechanical overload or muscle injury. By regulating the transcription of myogenic regulatory factors, GLI3 influences muscle progenitor cell self-renewal, satellite cell expansion, and subsequent myonuclear donation essential for sustained fiber remodeling.
Clinical and Fitness Research Findings
The primary clinical interest in rs10263647 stems from genome-wide association investigations evaluating physiological adaptations to resistance exercise. In a pivotal study examining training-induced adaptations, rs10263647 met genome-wide thresholds for association with changes in vastus lateralis mean muscle fiber cross-sectional area (fCSA). Participants carrying one or two copies of the C allele (T/C and C/C genotypes) demonstrated statistically significant increases in myofiber size, satellite cell counts, and myonuclear addition following structured training protocols. Conversely, individuals with the homozygous T/T genotype showed blunted fCSA expansion and lacked significant myonuclear addition. However, the evidence supporting this association remains moderate: findings have been derived from targeted cohort studies with relatively modest sample sizes, meaning further large-scale replication across diverse populations is necessary to confirm the exact effect size.
Population Frequency and Allele Distribution
The rs10263647 variant is common across global populations, making both alleles standard genomic findings rather than rare anomalies. Population genomic data reflect that the minor cytosine (C) allele occurs at an estimated frequency of approximately 0.38 to 0.40 in European and East Asian cohorts, while the ancestral thymine (T) allele is present at an estimated frequency of roughly 0.60 to 0.62. Heterozygous carriers (T/C) represent a substantial portion of the population, whereas homozygous C/C individuals constitute a smaller subset. Because these alleles are distributed widely across ancestral backgrounds, the physiological traits associated with the polymorphism reflect common human variation rather than pathological conditions.
Practical Implications and Lifestyle Considerations
While finding an association between rs10263647 and muscle fiber hypertrophy offers fascinating insight into skeletal muscle biology, this genetic result should not be viewed as a strict determinant of physical capability. Genetic variations contribute only a fraction of the overall variability observed in athletic performance and muscle adaptation. Progressive resistance exercise, balanced nutritional intake, adequate dietary protein, and proper recovery remain the primary physiological drivers of muscle hypertrophy regardless of genotype. Carrying the T/T genotype does not preclude an individual from building muscle or improving overall physical conditioning, nor does carrying the C allele guarantee effortless hypertrophy. Readers should view this variant as an interesting marker of biological variance rather than a diagnostic indicator or a reason to modify standardized training tenets.
How common is this variant?
The C allele occurs at a frequency of approximately 0.38 to 0.40 among European and East Asian populations, while the ancestral T allele occurs at approximately 0.60 to 0.62.
Frequently asked questions
Can I still build muscle if I have the TT genotype for rs10263647?
Yes. While studies indicate that individuals with the TT genotype may exhibit less pronounced microscopic fiber hypertrophy in specific training protocols, overall muscle adaptation and functional strength are complex traits influenced by hundreds of genes, training consistency, and nutrition.
Does rs10263647 cause any genetic disorders?
No, rs10263647 is a common non-coding intronic polymorphism that is not classified as a pathogenic mutation or causal for Mendelian genetic disorders. While rare loss-of-function mutations in GLI3 can cause developmental syndromes, rs10263647 represents benign normal variation.
How does GLI3 influence muscle growth after lifting weights?
The GLI3 gene encodes a transcription factor involved in the Hedgehog signaling pathway, which helps direct the activation, proliferation, and fusion of muscle stem cells known as satellite cells. Effective satellite cell activity donates new nuclei to existing fibers, supporting long-term muscle remodeling.
Should I change my workout routine based on my rs10263647 genotype?
No, you should not restructure your fitness program based solely on this single variant. Evidence-based training principles—such as progressive overload, adequate protein intake, and sufficient rest—apply universally across all genotypes.
Sources & further reading
Educational information only, last refreshed 9/5/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs10263647?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29